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Abstract
Jungia sellowii (Asteraceae) is a shrub that grows in Southern Brazil and polar extract of its leaves presents anti-inflammatory
properties. Cyperane, guaiane, nortrixane, and trixane sesquiterpene types were reported as the main metabolites in Jungia species.
This work aims to describe the isolation and identification of sesquiterpenes in the leaves of J. sellowii using liquid–liquid partition
and centrifugal partition chromatography. Thus, the crude extract of fresh leaves of J. sellowii was partitioned with hexane,
dichloromethane, ethyl acetate and butanol, respectively. The butanol fraction was then subjected to a selected ternary system opti-
mized for the CPC (centrifugal partition chromatography): ethyl acetate–ethanol–water (9:2:10, v/v/v). The separation was carried
out isocratically at a flow rate of 25 mL/min at 1200 rpm, affording seven fractions A to G. TLC of fractions B, C and F displayed a
single spot corresponding to three new glycosylated sesquiterpenoids. Their structures were established by using spectroscopic data
in comparison to those reported in the literature. Furthermore, the isolates were evaluated for their leishmanicidal and cytotoxic
effects. No cytotoxic effect was observed against the three cancer cell lines (HL60, JURKAT and REH), but compound 1 showed a
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weak antiprotozoal activity. Liquid–liquid partition and CPC turned to be a versatile technique of glycoside purification which is
environmentally friendly and requires a limited amount of organic solvents.
Introduction
Jungia (Asteraceae) comprises shrubs, lianas and herbs, widely
distributed from Central to South America, including Southern
Brazil. Species such as J. paniculata and J. polita are used in
South America to disinfect and cure external wounds, to treat
inflammation [1,2], and as a blood depurative [3]. Pharmaco-
logical studies demonstrated that the anti-inflammatory and
antioxidant effects of J. paniculata were associated to the pres-
ence of flavonoids and other polyphenols [4]. Recently, we re-
ported the in vivo anti-inflammatory properties of an aqueous
fraction of the leaves of J. sellowii, that is in agreement with its
popular use in Brazil [5].
Apart from the polyphenols identified in Jungia species,
sesquiterpenoids with guaiane, guaiene, nortrixane, trixane
(isocedrene), and cyperane scaffolds are also representative of
this genus [6-9]. These terpenoids demonstrated a wide range of
bioactivities [10-12], and hit compounds such as artemisinine,
thapsigargin, and parthenolide are used nowadays for the treat-
ment of malaria and cancer and have shown antileishmanial ac-
tivities [13,14].
About two million new cases of Leishmania infection are
considered to occur every year in tropical countries including
Brazil. Today no effective vaccine for the prevention of Leish-
mania diseases exist, whereas current chemotherapy is ineffec-
tive due to the high toxicity, the emergence of drug resistance,
and the high cost of treatment, among others [15-17]. Conse-
quently, infected people betake of medicinal plants as an alter-
native to provide treatment.
Plants also have an important role as a source of antitumoral
agents, and several anticancer drugs currently in use are derived
from natural sources. Natural products often have selective bio-
logical actions due to binding affinities for specific proteins,
and have superior chemical diversity and complexity, and
frequently have more advantageous ADME/T properties [18].
Compared to other chromatographic methods, centrifugal parti-
tion chromatography (CPC) is compatible with green chemistry
criteria since it does not use any polluting solid support such as
silica. Moreover, it allows the complete recovery of the injected
extract without degradation and only requires a limited amount
of organic solvents [19], and it turned to be a versatile method
of separation for the isolation of glycosides [20,21].
Based on the above observation, our aims were to identify new
metabolites from J. sellowii and assess their antileishmanial and
cytotoxic effects. To the best of our knowledge, there are no
reports dealing with the isolation and structure characterization
of glycosylated sesquiterpene derivatives from Jungia sellowii.
Results and Discussion
CPC separation
The aerial parts crude extract of Jungia sellowii was investigat-
ed using liquid–liquid partition and centrifugal partition chro-
matography (CPC), which is related to the counter-current chro-
matography (CCC) [22]. The chromatographic behavior of the
butanol fraction of the leaves of J. sellowii was evaluated in six
different biphasic systems consisting of different proportions of
ethyl acetate (EtOAc)/ethanol (EtOH)/H2O by using the shake-
flask method [23] (Table 1). These trials considered the perfor-
mance of the phase’s separation and also the spots profile when
monitored by TLC. Among them, the mixture of EtOAc/EtOH/
H2O (9:2:10, v/v/v) gave a better separation, and it was used in
the CPC equipment (details described in the experimental
section) from which three new glycosylated sesquiterpenes
were achieved in a single run in less than two hours (Figure 1).
The compounds were identified to be two trixanolides and one
guaianedienone (Figure 2) and the partition coefficient calcu-
lated for compounds 1 (16.20), 2 (2.77) and 3 (13.51)
(Figure 1).
Table 1: Experimental conditions evaluated by using the shake-flask
method.
Condition Ethyl acetate Ethanol Water
1 9 2 10
2 8 2 10
3 7 2 10
4 9 1 10
5 9 3 10
6 8 3 10
Sesquiterpenes were previously reported from the genus Jungia
[6,7,24-26]. Nevertheless, no glycosylated sesquiterpenes (and
sesquiterpene lactones) were previously found in this genus.
CPC has been used in a semi-empirical mode [20] as a replace-
ment of vacuum liquid chromatography (VLC) or reversed-
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Figure 1: UPLC profile of the butanol fraction of the leaves of Jungia sellowii after shaking the flask with the selected biphasic system (details in the
Experimental section). UP: upper phase (top chromatogram), LP: lower phase (bottom chromatogram). Detection at 242 nm.
Figure 2: Structures of compounds 1–3.
phase medium pressure liquid chromatography (MPLC),
permitting specially the isolation of several terpene glycosides
[27], such as a geranyl disaccharide [28], natural [29,30],
semisynthetic iridoid derivatives [31], and diterpene glycosides
[32]. This technique was for the first time used with Jungia
extracts.
Elucidation of the compounds
Compound 1 was obtained as colorless gum. The molecular
formula C21H30O8 was determined from its ESI–HRMS spec-
trum which gave the cationic ion peak [M + H]+ at m/z
411.1997 (calcd for 411.2019). The elemental composition indi-
cated seven double bond equivalents. The 13C NMR spectrum
of 1 displayed 21 signals: one CH3 group, seven CH2 groups,
nine CH groups and four quaternary carbons. The study of the
HSQC NMR correlation map revealed that among the CH2
groups, three were oxygenated while the CH groups included
one anomeric (δ 4.28/104.7, Table 2 and Table 3), one olefin (δ
6.79/139.7), and four bearing oxygen (δ 3.20/75.0, 3.38/78.0,
3.32/71.8, and 3.30/77.4). A sugar moiety was deduced mainly
from HSQC and COSY correlations observed between the
oxymethine groups, the hemi-acetal and one of the CH2O
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Table 2: 1H NMR data [400 MHz, (CD3)2CO] of compounds 1–3.
Position Aglycone
1 2 3
1 1.66 (m), 2.07 (m) 1.72 (dd, 4.4, 11.5 Hz),
1.80 (br d, 11.5 Hz)
3.35 (m)
2 2.38 (m) 2.17 (m) 1.96 (m),
2.24 (dd, 7.2, 18.4)
3 2.44 (t, 3.6 Hz) 4.43 (dd, 2.1, 4.1 Hz) –
4 6.79 (t, 3.6 Hz) 6.71 (dd, 1.5, 4.1 Hz) –
5 – – –
6 – – 4.93 (br s)
7 2.11 (m) 2.14 (m) 1.97 (m)
8 1.58 (m), 2.00 (m) 1.71 (m), 2.05 (m) 1.09 (m), 1.30 (m)
9 1.63 (m), 1.69 (m) 1.56 (m), 1.67 (m) 1.57 (m), 2.02 (m)
10 2.12 (overlapped) 1.90 (m) 2.51 (m)
11 – – –
12 1.12 (s) 1.05 (s) 1.91 (br s)
13 3.39 (d, 9.2 Hz),
3.82 (d, 9.2 Hz)
1.10 (s) 4.82 (m), 4.97 (br s)
14 4.04 (dd, 5.5, 11.7 Hz), 4.17 (dd, 4.3, 11.7 Hz) 4.11 (dd, 4.9, 11.7 Hz),
4.25 (dd, 4.2, 11.7 Hz)
0.93 (d, 7.2 Hz)
15 – – 1.66 (br d, 2.2 Hz)
Glucopyranosyl
1´ 4.28 (d, 7.7 Hz) 4.47 (d, 7.7 Hz) 4.39 (d, 7.8 Hz)
2´ 3.20 (pseudo-t, 8.3 Hz) 3.16 (dd, 7.7, 8.8 Hz) 3.27 (m)
3´ 3.38 (m) 3.38 (m) 3.24 (m)
4´ 3.32 (m) 3.33 (m) 3.33 (m)
5´ 3.30 (m) 3.33 (m) 3.37 (m)
6´ 3.65 (dd, 5.0, 11.5 Hz),
3.83 (m)
3.66 (dd, 4.9, 11.7 Hz),
3.83 (dd, 7.8, 11.7 Hz)
3.55 (dd, 5.5, 11.7 Hz)
3.69 (dd, 3.1, 11.7 Hz)
(δ 3.65, 3.83/63.0) groups. Furthermore, the quaternary carbons
included an α,β-unsaturated carbonyl (δ 165.5), an olefinic car-
bon (δ 137.5) and two sp3 carbons (δ 47.7 and 53.8). Fifteen
carbon shifts remained after the sugar deduction suggesting the
aglycone to be a sesquiterpene [33]. Based on previous reports,
the signals of a CH group at δ 2.12/65.2 (C-10) and a quater-
nary carbon at δ 53.8 (C-6) observed in the NMR spectra of
compound 1 suggested a trixane scaffold for this secondary
metabolite [34]. C-10 and C-6 are respectively shared by two
and four strained rings in the trixane skeleton, explaining their
downfield resonances. COSY correlations (Figure 3) revealed
from H-10 (δ 2.12) to H-9 (δ 1.63, 1.69), H-9 to H-8 (δ 1.58,
2.00), H-8 to H-7 (δ 2.11) which in turn correlated with H-14
(δ 4.04, 4.17) in addition to the HMBC correlations (Figure 3)
from H-10 to C-6 (δ 53.8), H-7 to C-6, and H-14 to C-15
(δ 165.5) allowed to form the rings B and C. Moreover, C-6 had
a long-range correlation with H-1 (δ 1.66, 2.07) which in turn
displayed a COSY contact with H-2 (δ 2.38). This latter also
correlated with H-3 (δ 2.44) which showed a similar interaction
with H-4 (δ 6.79). The above correlations together with the
long-range heteronuclear interactions between H-4 and C-6, as
well as H-3, C-4 (δ 139.7) and C-5 (δ 137.5) allowed deducing
the ring A. The last ring was established from the HMBC corre-
lations observed between the protons of Me-12 and carbons C-2
(δ 43.0), C-10 (δ 65.2), C-11 (δ 47.7), and C-13 (δ 76.4). The
sugar moiety was identified as glucopyranosyl by comparing its
chemical shift with those formerly reported [35]. It was further
attached to the aglycone at C-13 since H-13 (δ 3.39, 3.82)
correlated with the anomeric carbon (104.7). NOE correlations
(Figure 4) usually found in the β-D-glucopyranosyl core were
also revealed between the anomeric proton H-1’ (δ 4.28), H-3’
(δ 3.38), and H-5’ (δ 3.30). The relative configuration of the
aglycone was tentatively determined based on NOESY contacts
observed between H-12, H-10, and H-3. Similarly, H-13
unveiled the same interactions with H-1 and H-9 while H-14
correlated with H-8 (Figure 4). In order to determine the
absolute configuration of the compounds 1–3, ECD spectra
prediction was used [36,37]. The absolute configuration of 1
was assigned as 2R, 6S, 7R, 10R, and 11S by ECD analysis sup-
ported by the theoretical calculation using time-dependent den-
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Figure 3: COSY and HMBC correlations of compounds 1–3.
Figure 4: NOESY correlations of compounds 1–3.
Table 3: 13C NMR data [100 MHz, (CD3)2CO] of compounds 1–3.
Position Aglycone
1 2 3
1 39.5 35.7 44.6
2 43.0 53.4 36.8
3 32.3 74.9 208.5
4 139.7 137.3 134.0
5 137.5 139.5 177.8
6 53.8 54.7 80.9
7 40.3 40.5 52.3
8 31.0 31.5 30.1
9 25.9 27.0 29.2
10 65.2 63.2 33.2
11 47.7 40.1 149.3
12 24.7 28.7 22.9
13 76.4 28.4 110.9
14 68.7 68.8 20.3
15 165.5 165.6 7.4
Glucopyranosyl
1´ 104.7 103.6 104.8
2´ 75.0 74.9 74.8
3´ 78.0 78.0 77.1
4´ 71.8 71.7 70.9
5´ 77.4 77.6 76.5
6´ 63.0 63.0 62.1
sity functional theory. Thus, two Cotton Effects (CE) from the
n→π* transition of the α,β-unsaturated lactone were revealed at
225 and 275 nm with alternative signs (Figure 5). The afore-
mentioned data in conjunction to the absolute configuration pre-
viously reported for trixanolides [34], led to identify compound
1 as a new member of the trixane sesquiterpenoids. The trivial
name jungioside A was assigned.
Compound 2 was obtained as a colourless gum. The molecular
formula C21H30O8 was determined from its ESI–HRMS which
gave the cationic ion peak [M + H]+ at m/z 411.2013 (calcd for
411.2013). The elemental composition was consistent with
seven double bond equivalents. The NMR spectra of compound
2 displayed similar features as compound 1 except for the pres-
ence of one more CH3 group, an additional CH group and the
absence of two CH2 groups. The presence of resonances at
δ 54.7 (C-6) and δ 1.90/63.2 (H-10/C-10) suggested 2 to be also
a trixane-type as its congener 1 [1,2]. The sugar moiety was at-
tached at C-3 based on COSY correlation (Figure 3) of H-4
(δ 6.71) and H-3 (δ 4.43) in addition to the long-range correla-
tion observed in the HMBC spectrum (Figure 3) from H-3 to
the anomeric carbon (δ 103.6). The coupling constant of the
anomeric proton (J = 7.7 Hz) and the NOESY correlation of this
latter with H-3´ (δ 3.38) and H-5´ (δ 3.33) were consistent with
β-D-glucopyranosyl moiety [38]. Besides, the stereochemistry
of chiral centers in the aglycone was tentatively assigned as
Beilstein J. Org. Chem. 2016, 12, 674–683.
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Figure 5: ECD spectra of compounds 1–3.
those previously reported for the trixane skeleton. Relative con-
figurations of compound 2 turned to be similar as that of com-
pound 1 since H-12 (δ 1.05) revealed NOE contact (Figure 4)
with H-3 (δ 4.43) and H-10 (δ 1.90) likewise, H-13 (δ 1.10)
showed similar interactions with H-1 (δ 1.72) and H-9 (δ 1.56,
1.67).
The absolute configuration of 2 was determined to be 2R, 3S,
6S, 7R, and 10S by ECD analysis. As compound 1, two Cotton
Effects (CE) from the n→π* transition of the α,β-unsaturated
lactone were revealed at 225 and 275 nm with alternative signs
(Figure 5). The complete assignment in conjunction to the data
found in the literature led to identify compound 2 as new
trixane congener (Figure 2). The trivial name jungioside B was
given.
The NMR data of 3 revealed signals of a β-D-glucopyranosyl
(δ 4.39/104.8, 3.27/74.8, 3.24/77.1, 3.33/70.9, 3.37/76.5, 3.55
and 3.69/62.1) as found in the above-mentioned compounds and
signals of fifteen carbons suggesting another sesquiterpene
bearing a sugar moiety. The diagnostic of 2D experiments
permitted to identify the aglycone as a guaiane-type sesquiter-
pene whose the structure was consistent with 6-hydroxyguaiane
previously reported [39]. Moreover, the HMBC correlation
(Figure 3) from the hydrogen at δ 4.93 to the anomeric carbon
(δ 104.8) revealed the presence of an osidic bond. Thus, the mo-
lecular formula C21H32O7 was deduced from the aforemen-
tioned information in conjunction to the ESI–HRMS which
gave the pseudo-molecular ion peak at m/z 397.2239 [M + H]+
(calcd. 397.2226). The elemental composition corresponded to
six double bond equivalents. Some spatial correlations were ob-
served in the NOESY spectrum from H-1 to H-14 and from H-6
to H-7 consistent with the relative configuration reported the
aglycone [39]. The absolute configuration of 3 was assigned as
1R, 6R, 7S, and 10S. Three CE's were observed on the experi-
mental ECD spectrum at 240, 305 and 350 nm due to the n→π*
transition of the α,β-unsaturated ketone. The foregoing data led
to identify 3 as 6-hydroxyguaiane congener (Figure 2) and the
trivial name guaianoside was given.
Trixane derivatives have recently been reported as antileishma-
nial metabolites [40], and on the basis of these results the buta-
nol fraction from the areal parts crude extract as well as its iso-
lated compounds (1–3) were evaluated for their leishmanicidal
activity against L. donovani, L. infantum and L. amazonensis
(promastigotes and intracellular amastigotes). The cytotoxicity
of the butanol fraction in murine macrophages was found weak,
with an IC50 value at 290 μg/mL. However, the butanol frac-
tion displayed activity against L. amazonensis intracellular
amastigotes with an IC50 value of 100 μg/mL. Except for com-
pound 1 that exhibited a weak antileishmanial activity at 50 μM
(20%) against L. amazonensis intracellular amastigotes, none of
the other sesquiterpenes displayed antiparasitic activity.
Compounds 1–3 showed less than 50% antiproliferative effect
on leukemic cell lines HL60, JURKAT and REH at 15 μM.
Conclusion
The chemical study of the leaves of J. sellowii led to the isola-
tion and characterization of three new sesquiterpene glycosides,
including the first report of trixane lactone glycosides.
Liquid–liquid partition and CPC proved to be a very useful
technique for the investigation of polar extracts. Moreover, the
commercial availability of industrial instruments enables scale-
up to batch production for high-scale isolation. The CPC tech-
nique turned to be a versatile analytical tool leading to the
purification and identification of new glycosylated sesquiter-
penes including a rare skeleton (trixane). Only few of them
were described from the genus Jungia along with poly-
acetylenes, coumarins and flavonoids [6,7,24-26]. Globally,
the tested glycosylated sesquiterpenes displayed no or weak
activity against Leishmania strains, and displayed no cytotoxici-
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ty against murine macrophages and the leukemic cancer cell
lines.
Experimental
Solvents, materials and instruments
Ethanol for extraction and organic solvents for partitioning
(hexane, dichloromethane, ethyl acetate, and butanol) as well as
for CPC were pro-analysis grade (p.a.). Water was distilled
from deionized water whereas MeOH and acetonitrile for
UHPLC were of analytical grade (HPLC grade).
Merck precoated silica gel 60 F254 plates, 0.25 mm thickness,
were used for analytical thin-layer chromatography. The visual-
ization of spots on TLC plates was effected by exposure to UV
254 nm and by spraying with sulfuric vanillin solution at 30%
and heating. The mobile phase used to monitor the method de-
velopment and the fractions was composed by EtOAc/CH2O2/
AcOH/H2O (60:0.6:0.6:20). The 1D and 2D NMR experiments
were recorded with Bruker AC-300 and Bruker Avance-400
spectrometers at 400 MHz for 1H and 2D NMR and at 75 MHz
for 13C NMR. The spectra were recorded using deuterated sol-
vents CDCl3 and CD3OD. Chemical shifts (δ) are expressed in
ppm with reference to the TMS signal (δH/δC 0.0) and coupling
constants are reported in Hz. The 2D NMR experiments
(COSY, HSQC, HMBC, and NOESY) were performed using
standard Bruker microprograms. UPLC-PDA analyses were
performed on a Waters Acquity H UPLC quaternary system
manager equipped with a Acquity sample manager and a PDA
detector. Data were processed with Empower 3 software. CPC
separation was performed on a SCPC-250+1000-B apparatus
provided by Armen Instrument (Saint-Avé, France) fitted with a
1000 mL rotor containing 2016 twin-cells, equipped with a
gradient pump and a 50 mL loop injection 6-way valve.
Electronic circular dichroism (ECD) spectra were recorded in
acetonitrile using a Jasco XLC 3195CD detector.
Plant material
The leaves of J. sellowii Less. were collected in Rio Negrinho,
Santa Catarina, Brazil, in March 2012. Plant identification was
performed by the botanist Dr. Ademir Reis from the botany
department at the Federal University of Santa Catarina, and a
voucher specimen (RB number 537.991) is preserved in the
Jardim Botanico do Rio de Janeiro, Brazil.
Measurement of the partition coefficient
(K value)
First, the selected solvent system (EtOAc/EtOH/H2O, 9:2:10,
v/v/v) was prepared and equilibrated, then 1 mL of the upper
phase and 1 mL of the lower phase were taken to a test tube and
about 1 mg sample was added into it. The test tube was shaken
vigorously and allowed to settle for 5 min. About 0.5 mL of
upper and lower phases were taken into two vials and evaporat-
ed under nitrogen. The residues of each phase were dissolved in
1 mL of methanol and were then analyzed by UPLC (Figure 1).
The K value was expressed as the peak area of compounds in
upper phase divided by that in the lower phase.
Chromatographic conditions employed for the peak area mea-
surement were column Acquity UPLC BEH C18 1.7 µm (2.1 ×
50 mm), with a flow rate of 0.3 mL/min using gradient mode
composed of formic acid 0.1% (A) and acetonitrile (B): starting
85% of A, changing to 82% of A in 3 min, to 78% of A in
5 min, to 65% of A in 10 min, returning to the initial conditions
in 12 min. The detection was done at a wave length of 242 nm.
Computational details (ECD)
All calculations were conducted using Gaussian 09W [41].
After geometry optimization using density functional theory
(DFT) at the B3LYP/6-311+g (d,p) level of theory. A check for
imaginary frequencies was performed in order to confirm the
presence of a real minimum. Calculations of the rotational
strengths and excitation energies were realized using time de-
pendent (TD) DFT at the same level of theory. ECD spectra
were plotted using the SpecDis v1.61 software [42].
Extraction, fractionation and isolation proce-
dure
Fresh leaves of J. sellowii (1.8 kg) were macerated in 3 L of
EtOH/H2O (1:1) that after solvent removal furnished 40 g of
crude extract. This crude extract was dissolved in 600 mL of
cold water and partitioned with solvents of increasing polarity,
giving hexane (hex, 0.4 g), dichloromethane (DCM, 1 g), EA
(0.6 g) and BuOH (4.6 g) fractions, together with the remaining
aqueous fraction (lyophilized, 31.9 g). CPC separation of the
BuOH fraction (4 g) was carried out in the optimized biphasic
system composed by EtOAc/EtOH/H2O, 9:2:10, v/v/v, shaken
in a separatory funnel and kept until the phase separation.
The separation was then conducted in isocratic ascending mode
at room temperature, using the lower phase of the previously
prepared mixture as stationary phase and the upper phase as
mobile phase. The 1 L column was first filled with the lower
phase in ascending mode at a flow-rate of 50 mL/min at
500 rpm. Rotation speed was then set up at 1200 rpm and the
mobile phase pumped through the stationary phase at a flow-
rate of 25 mL/min until equilibration. The retention volume was
determined as 320 mL.
The butanol fraction was injected after dissolution in 20 mL of
a mixture 1:1 of the selected biphasic system. 70 fractions of
50 mL were collected in the ascending mode. After switching to
Beilstein J. Org. Chem. 2016, 12, 674–683.
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descending mode, 20 additional fractions of 50 mL were
collected. Extrusion process started after finishing collection of
the tubes by pumping the stationary phase into the column at a
flow rate of 25 mL/min. Fractions collected in the descending
mode (tubes 70–90) did not lead to any interesting outcome.
However, Fractions from the ascending mode were pooled
together based on their TLC profile affording fractions A–G.
Fractions B (96 mg), C (85 mg) and F (90 mg) provided a single
spot on the TLC plate, resulting in the elucidated new glycosy-
lated sesquiterpenoids 3, 2 and 1, respectively (Figure 2).
Compound 1: colourless gum; IR λmax (cm−1): 3390.8, 2924.2,
1705.7, 1627.9, 1420.8, 1363.4, 1265.9, 1221.8, 1162.1, 1077.4,
1035.0; ESI–HRMS m/z 411.1997 [C21H30O8 + H]+ (calcd.
411.2019), 821.3940 [2M + H]+. For 1H and 13C NMR data see
Table 2 and Table 3.
Compound 2: colourless gum; IR λmax (cm−1): 3396.4, 2924.4,
2872.4, 1704.7, 1458.8, 1364.4, 1266.2, 1221.3, 1074.8,
1036.4; ESI–HRMS m/z 411.2013 [C21H30O8 + H]+ (calcd.
411.2019), 433.1839 [M + Na]+. For 1H and 13C NMR data see
Table 2 and Table 3.
Compound 3: colourless gum; IR λmax (cm−1): 3376.4, 2938.0,
1688.2, 1080.5; ESI–HRMS m/z 397.2239 [C21H32O7 + H]+
(calcd. 397.2226), 793.4391 [2M + H]+. For 1H and 13C NMR
data see Table 2 and Table 3.
Bioactivity tests
Evaluation of antileishmanial activity
L. donovani (strain LG13, MHOM/ET/0000/HUSSEN), L.
infantum (MHOM/GR/2002/GH12) and L. amazonensis
(MPRO/BR/72/M1845) promastigotes and the murine macro-
phage J774 cell line (American Type Culture Collection,
Manassas, VA) were cultured in RPMI 1640 (RPMI) medium,
respectively, supplemented with 10% heat-inactivated fetal
bovine serum, 10 mM HEPES and antibiotics (penicillin/
streptomycin) as previously described at 26 C [43]. The
inhibitory activity of compounds was determined with the use
of an MTT-based assay, the Alamar blue, as previously de-
scribed [44]. The 50% maximal inhibitory concentration (IC50)
was calculated using a nonlinear regression curve fit [45].
For evaluating the inhibitory activity of compounds against
intracellular amastigotes, J774 macrophages were seeded into
96-well flat bottom plates at a density of 2 × 105 cells/mL in
200 μL RPMI and were left to adhere overnight at 37 °C in 5%
CO2. 24 h later macrophages were infected with stationary
phase promastigotes at a ratio of 10 parasites per macrophage
and incubated for a further 24 h at 37 °C in 5% CO2 as previ-
ously described [44].
All experiments were performed at least three independent
times in triplicate.
In vitro cytotoxicity against leukemic cells
The cell lines used in this study were HL60 (Acute Promyelo-
cytic Leukemia), JURKAT (Acute T cell Leukemia) and REH
(Acute Lymphocytic Leukemia non-T; non-B). The cells were
grown in plastic bottles (75 cm3) containing RPMI 1640 (Sigma
R6504) medium supplemented with 10% fetal calf serum
(Gibco 16000-044), 1% penicillin (10000 IU/mL), and strepto-
mycin (10 mg/mL) (Gibco 15070) at 37 °C in humidified air
with 5% CO2. The medium was changed every 48 h.
The cytotoxicity of each compound in the cell lines indicated
above was determined by the MTT (3-(4,5-dimethylthiazol-2-
yl)-2-5-diphenyltetrazolium bromide) assay [46]. The absor-
bance was read in a Synergy ELISA plate reader (Bio Tek
Instruments, Highland Park, Winooski, USA) at 570 nm. The
results were expressed as percentage inhibition relative to
control cells (considered as 100%).
Supporting Information
Supporting Information File 1
NMR and MS spectra of compounds 1–3.
[http://www.beilstein-journals.org/bjoc/content/
supplementary/1860-5397-12-68-S1.pdf]
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